Private company

HilleVax, Inc.

American biological products company, incorporated in Delaware.

Last updated Oct 18, 2026.

Overview

  • IndustryBiological Products, (No Diagnostic Substances)
  • HeadquartersDE
  • Incorporated inDE2
  • Business address321 Harrison Ave, Suite 500, Boston, Ma 021182
  • Filer category, Emerging growth company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income345-$155.3M in 2024+191% since 2021
-$200.0M-$150.0M-$100.0M-$50.0M02021: -$53.4M-$53.4M20212022: -$65.1M-$65.1M2022+22%2023: -$133.3M-$133.3M2023+105%2024: -$155.3M-$155.3M2024+16%
Net income345-$147.3M in 2024+44% since 2021
-$200.0M-$150.0M-$100.0M-$50.0M02021: -$102.4M-$102.4M20212022: -$159.8M-$159.8M2022+56%2023: -$123.6M-$123.6M2023−23%2024: -$147.3M-$147.3M2024+19%
Fiscal year202020212022202320242025
Operating income-$53.4M3-$65.1M4-$133.3M5-$155.3M5
Interest$2.8M3$3.4M4$2.4M4
Net income-$102.4M3-$159.8M4-$123.6M5-$147.3M5
Earnings per share-$18.223-$5.894-$3.045-$3.005
Earnings per share (diluted)-$18.223-$5.894-$3.045-$3.005

Compare HilleVax, Inc. with another company

Leadership

Who has led HilleVax, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (11)

Timeline

  1. Apr 28, 2022New chief executive Robert Hershberg becomes CEO8

Filings

219 filings to the SEC since October 2021: 3 annual reports, 11 quarterly reports, 35 major events, 82 insider forms, 25 large holders, 63 other. The latest 20:

  1. Nov 14, 2025SCHEDULE 13G/A EDGAR
  2. Sep 29, 202515-12G EDGAR
  3. Sep 22, 2025EFFECT EDGAR
  4. Sep 22, 2025EFFECT EDGAR
  5. Sep 19, 20254 EDGAR
  6. Sep 19, 2025SCHEDULE 13D/A EDGAR
  7. Sep 19, 2025SCHEDULE 13D/A EDGAR
  8. Sep 17, 2025SCHEDULE 13D/A EDGAR
  9. Sep 17, 20254 EDGAR
  10. Sep 17, 2025S-8 POS EDGAR
  11. Sep 17, 2025POS AM EDGAR
  12. Sep 17, 2025POS AM EDGAR
  13. Sep 17, 20254 EDGAR
  14. Sep 17, 20254 EDGAR
  15. Sep 17, 20254 EDGAR
  16. Sep 17, 20254 EDGAR
  17. Sep 17, 20254 EDGAR
  18. Sep 17, 20254 EDGAR
  19. Sep 17, 20254 EDGAR
  20. Sep 17, 20254 EDGAR

The 219 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 25 such filings since October 2021, the latest 10:

  1. Nov 14, 2025SCHEDULE 13G/A
  2. Sep 19, 2025SCHEDULE 13D/A
  3. Sep 19, 2025SCHEDULE 13D/A
  4. Sep 17, 2025SCHEDULE 13D/A
  5. Jul 24, 2025SCHEDULE 13G
  6. May 2, 2025SCHEDULE 13D
  7. Nov 14, 2024SC 13G/A
  8. Nov 14, 2024SC 13G/A
  9. Jul 22, 2024SC 13G
  10. May 31, 2024SC 13D/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.